Value and increased cost sharing in the American health care system.
作者信息
Chernew Michael, Fendrick A Mark
出版信息
Health Serv Res. 2008 Apr;43(2):451-7. doi: 10.1111/j.1475-6773.2008.00847.x.
Abstract
摘要
相似文献
1
Value and increased cost sharing in the American health care system.
Health Serv Res. 2008 Apr;43(2):451-7. doi: 10.1111/j.1475-6773.2008.00847.x.
2
Prescription for patient-centered care and cost containment.
N Engl J Med. 2013 Aug 1;369(5):471-4. doi: 10.1056/NEJMsb1306639. Epub 2013 Jun 26.
3
Cost-sharing: a blunt instrument.
Annu Rev Public Health. 2009;30:293-311. doi: 10.1146/annurev.publhealth.29.020907.090804.
4
Do high-deductible health plans threaten quality of care?
N Engl J Med. 2005 Sep 22;353(12):1202-4. doi: 10.1056/NEJMp058209.
5
Individual Responsibility and Community Solidarity--The Swiss Health Care System.
N Engl J Med. 2015 Dec 3;373(23):2193-7. doi: 10.1056/NEJMp1508256.
6
A comment on the response from Graham Wright.
Aust Health Rev. 2003;26(1):10-1. doi: 10.1071/ah030010.
7
The rising prevalence of treated disease: effects on private health insurance spending.
Health Aff (Millwood). 2005 Jan-Jun;Suppl Web Exclusives:W5-317-W5-325. doi: 10.1377/hlthaff.w5.317.
8
The insurance industry's role in reforming delivery.
Front Health Serv Manage. 1992 Fall;9(1):36-40.
9
On broadening the definition of and removing regulatory barriers to a competitive health care system.
J Health Polit Policy Law. 1978 Fall;3(3):303-27. doi: 10.1215/03616878-3-3-303.
10
Cost sharing in health insurance.
N Engl J Med. 1995 Sep 14;333(11):733-4. doi: 10.1056/NEJM199509143331115.
引用本文的文献
1
Prescription copay reduction program for diabetic employees: impact on medication compliance and healthcare costs and utilization.
Am Health Drug Benefits. 2009 Jan;2(1):14-24.
2
Lung cancer treatment costs, including patient responsibility, by disease stage and treatment modality, 1992 to 2003.
Value Health. 2011 Jan;14(1):41-52. doi: 10.1016/j.jval.2010.10.006.
3
Out-of-pocket payments in arthritis: spur to prudent purchasing or red herring?
Arthritis Rheum. 2008 Aug;58(8):2225-7. doi: 10.1002/art.23724.
本文引用的文献
1
Coping with prescription drug cost sharing: knowledge, adherence, and financial burden.
Health Serv Res. 2008 Apr;43(2):785-97. doi: 10.1111/j.1475-6773.2007.00797.x.
2
Drug use patterns in severely mentally ill Medicare beneficiaries: impact of discontinuities in drug coverage.
Health Serv Res. 2008 Apr;43(2):496-514. doi: 10.1111/j.1475-6773.2007.00779.x.
3
Impact of multitiered copayments on the use and cost of prescription drugs among Medicare beneficiaries.
Health Serv Res. 2008 Apr;43(2):478-95. doi: 10.1111/j.1475-6773.2007.00774.x.
4
How effective are copayments in reducing expenditures for low-income adult Medicaid beneficiaries? Experience from the Oregon health plan.
Health Serv Res. 2008 Apr;43(2):515-30. doi: 10.1111/j.1475-6773.2007.00824.x. Epub 2008 Jan 29.
5
Impact of decreasing copayments on medication adherence within a disease management environment.
Health Aff (Millwood). 2008 Jan-Feb;27(1):103-12. doi: 10.1377/hlthaff.27.1.103.
6
Value-based insurance design: a "clinically sensitive, fiscally responsible" approach to mitigate the adverse clinical effects of high-deductible consumer-directed health plans.
J Gen Intern Med. 2007 Jun;22(6):890-1. doi: 10.1007/s11606-007-0188-2.
7
Value-based insurance design.
Health Aff (Millwood). 2007 Mar-Apr;26(2):w195-203. doi: 10.1377/hlthaff.26.2.w195. Epub 2007 Jan 30.
8
The value of coronary heart disease care for the elderly: 1987-2002.
Health Aff (Millwood). 2007 Jan-Feb;26(1):111-23. doi: 10.1377/hlthaff.26.1.111.
9
Value-based insurance design: aligning incentives to bridge the divide between quality improvement and cost containment.
Am J Manag Care. 2006 Dec;12 Spec no.:SP5-SP10.
10
Cost-effectiveness of full medicare coverage of angiotensin-converting enzyme inhibitors for beneficiaries with diabetes.
Ann Intern Med. 2005 Jul 19;143(2):89-99. doi: 10.7326/0003-4819-143-2-200507190-00007.
Zotero 插件